BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9556204)

  • 1. Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats.
    Kagawa T; Watanabe N; Sato M; Nakano A; Nishizaki Y; Hosoi K; Takashimizu S; Uchiyama J; Kimura M; Matsuzaki S
    Biochem Mol Biol Int; 1998 Mar; 44(3):443-52. PubMed ID: 9556204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.
    Lee JM; Trauner M; Soroka CJ; Stieger B; Meier PJ; Boyer JL
    Gastroenterology; 2000 Jan; 118(1):163-72. PubMed ID: 10611165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat.
    Jäger W; Winter O; Halper B; Salamon A; Sartori M; Gajdzik L; Hamilton G; Theyer G; Graf J; Thalhammer T
    Hepatology; 1997 Dec; 26(6):1467-76. PubMed ID: 9397986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver.
    Vos TA; Hooiveld GJ; Koning H; Childs S; Meijer DK; Moshage H; Jansen PL; Müller M
    Hepatology; 1998 Dec; 28(6):1637-44. PubMed ID: 9828229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of xenobiotic detoxification system mediated by efflux transporters].
    Suzuki H
    Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic canalicular membrane 4: expression of the multidrug resistance genes in the liver.
    Silverman JA; Schrenk D
    FASEB J; 1997 Apr; 11(5):308-13. PubMed ID: 9141496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.
    Hirohashi T; Suzuki H; Ito K; Ogawa K; Kume K; Shimizu T; Sugiyama Y
    Mol Pharmacol; 1998 Jun; 53(6):1068-75. PubMed ID: 9614210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.
    Paulusma CC; van Geer MA; Evers R; Heijn M; Ottenhoff R; Borst P; Oude Elferink RP
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):393-401. PubMed ID: 10024515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat.
    Accatino L; Pizarro M; Solís N; Koenig CS; Vollrath V; Chianale J
    J Hepatol; 1996 Sep; 25(3):349-61. PubMed ID: 8895015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2.
    Jedlitschky G; Leier I; Buchholz U; Hummel-Eisenbeiss J; Burchell B; Keppler D
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):305-10. PubMed ID: 9355767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid alterations in hepatocyte membranes and transporter protein changes in cholestatic rat model.
    Hyogo H; Tazuma S; Nishioka T; Ochi H; Yamaguchi A; Numata Y; Kanno K; Sakomoto M; Asamoto Y; Tsuboi K; Nakai K; Yasumiba S; Sunami Y; Kajiyama G
    Dig Dis Sci; 2001 Oct; 46(10):2089-97. PubMed ID: 11680581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
    Fardel O; Payen L; Courtois A; Vernhet L; Lecureur V
    Toxicology; 2001 Oct; 167(1):37-46. PubMed ID: 11557128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of inducible nature of MRP3 in rat liver.
    Ogawa K; Suzuki H; Hirohashi T; Ishikawa T; Meier PJ; Hirose K; Akizawa T; Yoshioka M; Sugiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G438-46. PubMed ID: 10712264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.
    Cherrington NJ; Slitt AL; Li N; Klaassen CD
    Drug Metab Dispos; 2004 Jul; 32(7):734-41. PubMed ID: 15205389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein.
    Sugiyama Y; Kato Y; Chu X
    Cancer Chemother Pharmacol; 1998; 42 Suppl():S44-9. PubMed ID: 9750028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2.
    Dietrich CG; Geier A; Salein N; Lammert F; Roeb E; Oude Elferink RP; Matern S; Gartung C
    Gastroenterology; 2004 Apr; 126(4):1044-53. PubMed ID: 15057744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
    Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
    Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
    Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.